Botensilimab,balstilimab
agenus
[]
final day of #gi23.
excited to see early response data from a phase 1 trial in mss colorectal cancer with botensilimab (novel immune activator ) and balstilimab (antipd1) - phase 3 enrolling now. 
The Colorectal Cancer Alliance is a national nonprofit fiercely dedicated to ending colorectal cancer within our lifetime. #TomorrowCantWait